#shionogi — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #shionogi, aggregated by home.social.
-
Jason Coloma: The FTC Killed Our Sanofi Deal. Six Months Later, We Had a Better One. — BigGo Finance
The Federal Trade Commission does not usually feature prominently in a biotech CEO’s business plan. For Jason Coloma,…
#France #FR #Europe #EU #Sanofi #APOL1 #AstraZeneca #BridgeBio #FTC #Genentech #JasonColoma #MazeTherapeutics #Parasol(UniversityofMichigan) #Pompedisease #Roche #Shionogi #SLC6A19 #ThirdRockVentures #VertexPharmaceuticals
https://www.europesays.com/france/64097/ -
The CEO of Shionogi says the firm is pursuing acquisition opportunities and considering expanding U.S. manufacturing capacity, as the Japanese drugmaker seeks to diversify its production base and geopolitical risk. https://www.japantimes.co.jp/business/2026/08/05/companies/shionogi-interview/?utm_medium=Social&utm_source=mastodon #business #companies #shionogi #pharmaceuticals #health #osaka #us
-
The CEO of Shionogi says the firm is pursuing acquisition opportunities and considering expanding U.S. manufacturing capacity, as the Japanese drugmaker seeks to diversify its production base and geopolitical risk. https://www.japantimes.co.jp/business/2026/08/05/companies/shionogi-interview/?utm_medium=Social&utm_source=mastodon #business #companies #shionogi #pharmaceuticals #health #osaka #us
-
The CEO of Shionogi says the firm is pursuing acquisition opportunities and considering expanding U.S. manufacturing capacity, as the Japanese drugmaker seeks to diversify its production base and geopolitical risk. https://www.japantimes.co.jp/business/2026/08/05/companies/shionogi-interview/?utm_medium=Social&utm_source=mastodon #business #companies #shionogi #pharmaceuticals #health #osaka #us
-
The CEO of Shionogi says the firm is pursuing acquisition opportunities and considering expanding U.S. manufacturing capacity, as the Japanese drugmaker seeks to diversify its production base and geopolitical risk. https://www.japantimes.co.jp/business/2026/08/05/companies/shionogi-interview/?utm_medium=Social&utm_source=mastodon #business #companies #shionogi #pharmaceuticals #health #osaka #us
-
The CEO of Shionogi says the firm is pursuing acquisition opportunities and considering expanding U.S. manufacturing capacity, as the Japanese drugmaker seeks to diversify its production base and geopolitical risk. https://www.japantimes.co.jp/business/2026/08/05/companies/shionogi-interview/?utm_medium=Social&utm_source=mastodon #business #companies #shionogi #pharmaceuticals #health #osaka #us
-
https://www.europesays.com/britain/60400/ GSK to Acquire Nuvalent for $10.6B, Boosting Cancer Pipeline with Precision NSCLC Treatments #AndTherapeutics #Cancer #cancers #diagnosis #DrugDevelopment(researchAndDevelopment) #FdaReview #GenEdge #GSK #IndustryNews #LungCancer #medicine #News #NonSmallCellLungCancer #Nuvalent #OrganonInternational #pfizer #RegulatoryPolicies #ResearchAndDevelopment #RoyaltyPharma #shionogi #SunPharmaceuticalIndustries #SystemicConditions
-
An experimental COVID-19 pill developed by Japan's Shionogi cut the risk of infection among people exposed to the disease at home. https://www.japantimes.co.jp/news/2026/05/14/japan/science-health/shionogi-covid-pill-post-exposure-study/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #shionogi #covid19 #pharmaceuticals #medicine
-
An experimental COVID-19 pill developed by Japan's Shionogi cut the risk of infection among people exposed to the disease at home. https://www.japantimes.co.jp/news/2026/05/14/japan/science-health/shionogi-covid-pill-post-exposure-study/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #shionogi #covid19 #pharmaceuticals #medicine
-
An experimental COVID-19 pill developed by Japan's Shionogi cut the risk of infection among people exposed to the disease at home. https://www.japantimes.co.jp/news/2026/05/14/japan/science-health/shionogi-covid-pill-post-exposure-study/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #shionogi #covid19 #pharmaceuticals #medicine
-
An experimental COVID-19 pill developed by Japan's Shionogi cut the risk of infection among people exposed to the disease at home. https://www.japantimes.co.jp/news/2026/05/14/japan/science-health/shionogi-covid-pill-post-exposure-study/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #shionogi #covid19 #pharmaceuticals #medicine
-
An experimental COVID-19 pill developed by Japan's Shionogi cut the risk of infection among people exposed to the disease at home. https://www.japantimes.co.jp/news/2026/05/14/japan/science-health/shionogi-covid-pill-post-exposure-study/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #shionogi #covid19 #pharmaceuticals #medicine
-
Cumulus Neuroscience Enters Japanese Market to Advance Novel Cognitive Biomarkers with New Customer Shionogi & Co., Ltd.
BELFAST, Northern I…
#Japan #JP #JapanNews #Alzheimer'sdisease #ClinicalTrials #cumulus #digitalhealth #Japanese #japanesemarket #Japanesenews #Ltd. #neurophysiologicaldata #news #observationalstudy #Shionogi&Co. #TheCompany
https://www.alojapan.com/1452197/cumulus-neuroscience-enters-japanese-market-to-advance-novel-cognitive-biomarkers-with-new-customer-shionogi-co-ltd/ -
Cumulus Neuroscience Enters Japanese Market to Advance Novel Cognitive Biomarkers with New Customer Shionogi & Co., Ltd.
BELFAST, Northern I…
#Japan #JP #JapanNews #Alzheimer'sdisease #ClinicalTrials #cumulus #digitalhealth #Japanese #japanesemarket #Japanesenews #Ltd. #neurophysiologicaldata #news #observationalstudy #Shionogi&Co. #TheCompany
https://www.alojapan.com/1452197/cumulus-neuroscience-enters-japanese-market-to-advance-novel-cognitive-biomarkers-with-new-customer-shionogi-co-ltd/ -
https://www.europesays.com/ie/297081/ Japan’s Shionogi boosts ViiV stake in $2.13 billion deal as Pfizer exits #Éire #Health #HealthCare #Healthcare #IE #Ireland #Japan #JointVenture #MajorityStake #pfizer #Shionogi #ViiV #ViiVHealthcare
-
Japanese pharmaceutical company Shionogi has lifted its full-year profit guidance as expected royalties from its HIV treatment surpass prior expectations. https://www.japantimes.co.jp/business/2025/10/28/shionogi-raises-profit-outlook/?utm_medium=Social&utm_source=mastodon #business #shionogi #hiv #pharmaceutical
-
Japanese pharmaceutical company Shionogi has lifted its full-year profit guidance as expected royalties from its HIV treatment surpass prior expectations. https://www.japantimes.co.jp/business/2025/10/28/shionogi-raises-profit-outlook/?utm_medium=Social&utm_source=mastodon #business #shionogi #hiv #pharmaceutical
-
Japanese pharmaceutical company Shionogi has lifted its full-year profit guidance as expected royalties from its HIV treatment surpass prior expectations. https://www.japantimes.co.jp/business/2025/10/28/shionogi-raises-profit-outlook/?utm_medium=Social&utm_source=mastodon #business #shionogi #hiv #pharmaceutical
-
Japanese pharmaceutical company Shionogi has lifted its full-year profit guidance as expected royalties from its HIV treatment surpass prior expectations. https://www.japantimes.co.jp/business/2025/10/28/shionogi-raises-profit-outlook/?utm_medium=Social&utm_source=mastodon #business #shionogi #hiv #pharmaceutical
-
Japanese pharmaceutical company Shionogi has lifted its full-year profit guidance as expected royalties from its HIV treatment surpass prior expectations. https://www.japantimes.co.jp/business/2025/10/28/shionogi-raises-profit-outlook/?utm_medium=Social&utm_source=mastodon #business #shionogi #hiv #pharmaceutical
-
Shares of Asian pharmaceutical companies fell after U.S. President Donald Trump announced a plan to order a cut in U.S. prescription drug costs to bring them in line with other countries. https://www.japantimes.co.jp/business/2025/05/12/markets/asian-pharma-trump-drug-price/?utm_medium=Social&utm_source=mastodon #business #markets #medicine #pharmaceuticals #us #republicans #donaldtrump #trade #tariffs #astellas #onopharmaceutical #sumitomopharma #shionogi #eisai #takeda #astellaspharma #otsukaholdings
-
Shares of Asian pharmaceutical companies fell after U.S. President Donald Trump announced a plan to order a cut in U.S. prescription drug costs to bring them in line with other countries. https://www.japantimes.co.jp/business/2025/05/12/markets/asian-pharma-trump-drug-price/?utm_medium=Social&utm_source=mastodon #business #markets #medicine #pharmaceuticals #us #republicans #donaldtrump #trade #tariffs #astellas #onopharmaceutical #sumitomopharma #shionogi #eisai #takeda #astellaspharma #otsukaholdings
-
Shares of Asian pharmaceutical companies fell after U.S. President Donald Trump announced a plan to order a cut in U.S. prescription drug costs to bring them in line with other countries. https://www.japantimes.co.jp/business/2025/05/12/markets/asian-pharma-trump-drug-price/?utm_medium=Social&utm_source=mastodon #business #markets #medicine #pharmaceuticals #us #republicans #donaldtrump #trade #tariffs #astellas #onopharmaceutical #sumitomopharma #shionogi #eisai #takeda #astellaspharma #otsukaholdings
-
Shares of Asian pharmaceutical companies fell after U.S. President Donald Trump announced a plan to order a cut in U.S. prescription drug costs to bring them in line with other countries. https://www.japantimes.co.jp/business/2025/05/12/markets/asian-pharma-trump-drug-price/?utm_medium=Social&utm_source=mastodon #business #markets #medicine #pharmaceuticals #us #republicans #donaldtrump #trade #tariffs #astellas #onopharmaceutical #sumitomopharma #shionogi #eisai #takeda #astellaspharma #otsukaholdings
-
Shares of Asian pharmaceutical companies fell after U.S. President Donald Trump announced a plan to order a cut in U.S. prescription drug costs to bring them in line with other countries. https://www.japantimes.co.jp/business/2025/05/12/markets/asian-pharma-trump-drug-price/?utm_medium=Social&utm_source=mastodon #business #markets #medicine #pharmaceuticals #us #republicans #donaldtrump #trade #tariffs #astellas #onopharmaceutical #sumitomopharma #shionogi #eisai #takeda #astellaspharma #otsukaholdings
-
Europe on the frontline in the fight against AMR [Promoted content] https://www.euractiv.com/section/health-consumers/opinion/europe-on-the-frontline-in-the-fight-against-amr/?utm_source=dlvr.it&utm_medium=mastodon #AMR #Antimicrobialresistance #Infectiousdisease #promoted #Shionogi
-
Europe on the frontline in the fight against AMR [Promoted content] https://www.euractiv.com/section/health-consumers/opinion/europe-on-the-frontline-in-the-fight-against-amr/?utm_source=dlvr.it&utm_medium=mastodon #AMR #Antimicrobialresistance #Infectiousdisease #promoted #Shionogi
-
Europe on the frontline in the fight against AMR [Promoted content] https://www.euractiv.com/section/health-consumers/opinion/europe-on-the-frontline-in-the-fight-against-amr/?utm_source=dlvr.it&utm_medium=mastodon #AMR #Antimicrobialresistance #Infectiousdisease #promoted #Shionogi
-
A Japanese health ministry panel has endorsed a COVID-19 vaccine developed by pharmaceutical company Daiichi Sankyo, a first for a domestically developed shot. https://www.japantimes.co.jp/news/2023/08/01/japan/science-health/japan-panel-endorses-first-domestically-developed-covid-vaccine/?utm_content=buffer0d11e&utm_medium=social&utm_source=mastodon&utm_campaign=bffmstdn #japan #sciencehealth #pharmaceuticals #daiichisankyo #covid19injapan #covid19vaccines #medicine #shionogi #covid19
-
A Japanese health ministry panel has endorsed a COVID-19 vaccine developed by pharmaceutical company Daiichi Sankyo, a first for a domestically developed shot. https://www.japantimes.co.jp/news/2023/08/01/japan/science-health/japan-panel-endorses-first-domestically-developed-covid-vaccine/?utm_content=buffer0d11e&utm_medium=social&utm_source=mastodon&utm_campaign=bffmstdn #japan #sciencehealth #pharmaceuticals #daiichisankyo #covid19injapan #covid19vaccines #medicine #shionogi #covid19
-
A Japanese health ministry panel has endorsed a COVID-19 vaccine developed by pharmaceutical company Daiichi Sankyo, a first for a domestically developed shot. https://www.japantimes.co.jp/news/2023/08/01/japan/science-health/japan-panel-endorses-first-domestically-developed-covid-vaccine/?utm_content=buffer0d11e&utm_medium=social&utm_source=mastodon&utm_campaign=bffmstdn #japan #sciencehealth #pharmaceuticals #daiichisankyo #covid19injapan #covid19vaccines #medicine #shionogi #covid19
-
A Japanese health ministry panel has endorsed a COVID-19 vaccine developed by pharmaceutical company Daiichi Sankyo, a first for a domestically developed shot. https://www.japantimes.co.jp/news/2023/08/01/japan/science-health/japan-panel-endorses-first-domestically-developed-covid-vaccine/?utm_content=buffer0d11e&utm_medium=social&utm_source=mastodon&utm_campaign=bffmstdn #japan #sciencehealth #pharmaceuticals #daiichisankyo #covid19injapan #covid19vaccines #medicine #shionogi #covid19
-
A Japanese health ministry panel has endorsed a COVID-19 vaccine developed by pharmaceutical company Daiichi Sankyo, a first for a domestically developed shot. https://www.japantimes.co.jp/news/2023/08/01/japan/science-health/japan-panel-endorses-first-domestically-developed-covid-vaccine/?utm_content=buffer0d11e&utm_medium=social&utm_source=mastodon&utm_campaign=bffmstdn #japan #sciencehealth #pharmaceuticals #daiichisankyo #covid19injapan #covid19vaccines #medicine #shionogi #covid19
